Introduction
Newly diagnosed epilepsy is estimated at 47 per 100,000 person-years [1] . One study on 5000 people with epilepsy (PWE) from 15 European countries reported that 96% of PWE were prescribed antiepileptic drugs (AEDs), among whom 88% reported at least one side effect (e.g. tiredness, memory problems, difficulty in concentrating or thinking clearly, nervousness and agitation, etc.) and 31% had changed their AEDs at least once in the last year because of side effects [2] . In addition, a diagnosis of epilepsy can impact on many aspects of persons' life. It may affect the ability to get or maintain employment [3] and driving licence [4] , impair health-related quality of life [5] and negatively impact on psychosocial functioning (e.g. experiencing stigma, anxiety and depression) [6, 7] . Accordingly, misdiagnosis may result in people unnecessarily experiencing the adverse effects of AEDs, those psychological and social impacts and may contaminate research cohorts of people with epilepsy.
The diagnosis of epilepsy is challenging with a low correlation between referral and specialist diagnosis [8] . False positive diagnoses are thought to occur in up to 25% of patients [9, 10] . Diagnosis is difficult due to varying seizure types and symptoms from visual hallucinations to tingling. Lack of awareness of imitators of epilepsy such as neuro-cardiogenic syncope [11] , daydream and benign paroxysmal vertigo is a common cause of misdiagnosis [12] . To date, only non-systematic literature reviews [12] [13] [14] have explored this topic. We performed a systematic review to determine the frequency of false positive diagnoses of epilepsy and to explore its imitators and consequences.
Methods
The protocol of this review was registered in Prospero [15] . The published protocol was modified to exclude studies of epileptic seizure, as a result 4 studies reporting the false positive diagnosis Seizure 41 (2016) [167] [168] [169] [170] [171] [172] [173] [174] 
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A systematic review of all published observational studies (to November 2015) was conducted to determine the proportion of false positive diagnoses of epilepsy. We included studies of people of all ages receiving a diagnosis of epilepsy. All observational study designs were included with the exception of case-reports and case series with fewer than 3 participants. Results: Data were available from 27 studies (31 reports), reporting considerably varied frequencies of false positive diagnoses. The frequency of false positive diagnosis range from 2% to 71%. The data also suggest that syncope and psychogenic non-epileptic paroxysmal events were the commonest imitators of epilepsy. Misdiagnosis led to mismanagement with anti-epileptic drugs (AEDs) and affected legal driving status and employment. Conclusions: False positive diagnosis of epilepsy is common, even though there is considerable heterogeneity across studies. All potential imitators should be considered and clinicians should be cautious introducing AEDs without a definite diagnosis given the risk of side effects, and the possible impact on legal driving status and employment.
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of index epileptic seizure [16] [17] [18] [19] were excluded. This review was restricted to published observational studies reporting the frequency of a false positive diagnosis of epilepsy. The study population included people (any age) who had been given an initial diagnosis of epilepsy. All observational study designs were included with the exception of case-reports and case series with fewer than 3 participants. All journal articles were included without language limitations. Studies were excluded if they had specific participant characteristic limits such as one sex (e.g. only males) or only people with disability with the exception of limits based on age.
Search strategy, data extraction and risk of bias assessment
Five databases were searched: MEDLINE, EMBASE, PsychINFO, CINAHL and AMED (from inception to 27 November 2015). The following search terms were used as free text or controlled vocabulary (i.e. medical subject headings, EMTREE) as appropriate for each database: epilepsy, seizures, convulsions, misdiagnosis, delayed diagnosis, diagnostic errors, incorrect diagnosis and missed diagnosis (full details available in the supplementary file). Titles and abstracts of all references were screened and full text articles were examined by three authors independently to determine whether they met the inclusion criteria. Further literature was sought through the reference lists of eligible studies. We did not check citation trails as early efforts indicated no yield.
Data extraction included region/country, recruitment site, study period, age, sample size, frequency of false positive diagnosis, aspects assessed to make the diagnosis and who made the diagnosis. Two researchers extracted data independently and cross-checked. When abstracts from conference were identified, we sought corresponding published journal articles. We reported data from the abstracts if corresponding journal articles could not be identified. We judged articles to be from the same cohort if there was evidence of overlapping recruitment sites, study dates, authorship and similar patient characteristics. Risk of bias was assessed using a 10-item assessment which reflected quality criteria for such studies.
Results
The search results and selection process are summarised in Fig. 1 . A total of 2334 references were identified, of which 149 full text articles were retrieved to assess for inclusion/exclusion and a total of 27 studies (31 reports) were considered eligible. The frequency of misdiagnosis was calculated in only 7% of the study population in Ojeda 2012 [20] . We were unable to identify corresponding journal articles for five conference abstracts [20] [21] [22] [23] [24] (three studies) and one brief communication [25] . We included the abstract [24] but not the whole paper [26] from the one study, because the frequency of misdiagnosis was not reported in the latter.
Patient characteristics
Twenty-six studies (Table 1 ) (Ojeda 2012 not included) reported the frequency of false positive diagnosis on 6912 people with epilepsy. The largest study [11] contributed 22% of patients, with the remaining studies ranging in size from 17 [27] to 850 [28] patients. Four studies included paediatric patients ( 18 years) only [28] [29] [30] [31] . Four were population-based [9, 10, 24, 32] studies recruiting patients from a base population of 75,200 [32] , 15,000 [24] , 200,000 [9] and 40,000 [10] , respectively. Five studies (nine reports [21] [22] [23] 27, [33] [34] [35] [36] [37] ) recruited patients from head up tilt test (HUTT) or implantable electrocardiogram (ECG) recorder (ILR) centres. The remaining 17 studies recruited patients from epilepsy centres or tertiary hospitals. One study [25] recruited patients with pseudo-refractory epilepsy, five studies (seven reports [34] [35] [36] [38] [39] [40] [41] ) recruited patients with refractory epilepsy.
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Diagnosis of epilepsy and frequency of false positive diagnosis
In six studies [20, 24, 32, [40] [41] [42] , the international classification of epileptic seizures and international classification of epilepsy and epileptic syndromes defined by International League against Epilepsy were used as the terminologies for the final diagnosis. Electroencephalogram (EEG) was used in 12 studies, video electroencephalography (v-EEG) was used in seven studies [27, 30, 38, 41, [43] [44] [45] and ambulatory electroencephalography (a-EEG) in four [30, 41, 46, 47] . Staff with expertise in epilepsy made the final diagnosis in only seven studies [10, 29, 32, 41, [46] [47] [48] . The frequency of false positive diagnosis range from 2% to 71% (Fig. 2) .
The proportions are presented stratified into subgroups on the basis of case selection (population-based, epilepsy centres or tertiary hospitals and Head up Tilt Test (HUTT), implantable electrocardiogram (ECG) recorder (ILR) centres). The squares are centred on the reported point estimates of effect; their size is large where the samples are larger, reflecting the relationship to the inverse of the variance. Horizontal lines represent 95% confidence intervals (CI).
Risk of bias assessment
In two studies (Table 2) , the study population was not consecutively recruited, with one population-based study [9] excluding 357 patients already attending the local epilepsy clinic and one study [41] excluding 248 patients who underwent previous long-term EEG. In four studies, the diagnosis was not reassessed by staff with expertise in epilepsy, and in 15, it was unclear who made the final diagnosis or whether the person had been trained.
The differential diagnosis
1249 out of the 6912 patients in 26 studies (Ojeda 2012 not included) were given an incorrect diagnosis of epilepsy. For 906 patients in 18 studies the imitators of epilepsy were reported. We listed all the reported differential diagnoses and grouped them into eight categories (Fig. 3) , according to a general epilepsy textbook [49] . Autism, mental retardation and learning disability were not mentioned in the textbook, but they were the predominant differential diagnoses in one study [30] . The ''others'' category included intoxication, encephalitis, massively reduced health condition, alcohol-related, post-anaesthetic, reaction to fright, hypoglycaemia and neoplasms. 475 cases of syncope from 15 studies and 314 cases of psychogenic non-epileptic paroxysmal events (NEPEs) from 12 studies were misdiagnosed as epilepsy.
The consequences of a false positive diagnosis
Four studies reported on the consequences of misdiagnosis [10, 11, 30, 39] . More than one-third of people with a false positive diagnosis of epilepsy were consequently mismanaged with AEDs. In one Canadian study, 67 (35%) out of 194 patients with neurocardiogenic syncope had been treated with AEDs, of whom adverse effects were reported in 35 (52%) [11] . Two cases of spontaneous abortion and one congenital left-sided hemiplegia were reported among the five pregnant women taking AEDs [11] . In one British study, 19 (39%) out of the 49 patients with misdiagnosis of epilepsy were on AEDs and 11 out of the 19 patients were on phenytoin and/or phenobarbital, without serum level monitoring [10] . In one Danish study, 35 (40%) out of the 87 children misdiagnosed with epilepsy were treated with AEDs [30] .
Misdiagnosis also affected legal driving status and employment. Out of 194 patients with neurocardiogenic syncope in the Canadian study, driving licences were formally revoked for 27 patients and informally restricted for 38 patients, while job restrictions were placed on 11 (6%) patients as a result of transportation (n = 8) or health concerns (n = 3) [11] . In another British study, 12 out of the 14 who possessed a driving licence had driving interrupted; three patients lost full-time jobs, one was demoted and one had to refuse a job which involved driving [39] .
Discussion
We report that the frequency of misdiagnosis of epilepsy range from 2% to 71%, with syncope and psychogenic NEPEs being the commonest imitators. Misdiagnosis leads to mismanagement with AEDs and affects legal driving status and employment. There was variation in estimates across studies due to potential moderator variables including the refractory/pseudo-refractory epilepsy, age of the study population, experience of the referring and consulting doctors, variations in the epilepsy diagnostic criteria used and methods to make the diagnosis (i.e. some or all of: written descriptions, videos of the episodes, EEG and neuroimaging), etc.
Lack of awareness of imitators is a common cause of misdiagnosis. Syncope is very common, with 15% of children and a similar percentage of middle aged men and women having ''an episode'' [50] . It is the sixth commonest cause of emergency admission in over 65-year olds in the UK [51] . HUTT and ILR have been suggested in patients with recurrent syncope and unexplained single syncope [50, 52] . Despite the incidence of psychogenic NEPEs being 1.4 per 100,000 [53] , 10-20% of patients referred to epilepsy centres have psychogenic NEPEs [54] Approximately 13% of patients with psychogenic NEPEs have coexistent epilepsy [55] . V-EEG is the gold standard for psychogenic NEPEs diagnosis [56] . Using data from v-EEG monitoring, researchers found that 50 of 52 patients with psychogenic NEPEs closed their eyes during the event, compared with 152 of 156 of patients with epilepsy, who kept their eyes open at the beginning of their event [57] . Without v-EEG, half of the psychogenic NEPEs were misclassified as epilepsy by neurologists based on history alone [58] . In addition, we acknowledge that a detailed history of events combined with EEG finding is the gold standard diagnostic method for epilepsy [49] . In this review, less than half of the studies used these methods. The value of clinical features and EEG has been highlighted. One study reported that an epileptic seizure is 5 times more likely than syncope if the patient is disoriented after the event and nausea or sweating are signs to exclude a seizure [59] . Another suggested when epilepsy is a reasonable possibility, a routine inter-ictal EEG can be a powerful diagnostic tool [60] .
In the UK, the National Institute for Clinical Excellence guidelines state that only a specialist paediatrician with expertise in epilepsy should establish the diagnosis of epilepsy in children and young people [12] , whereas specialist referral from general practitioners (GPs) is recommended after failure of two AEDs in Australia [61] . We are unable to compare the accuracy of diagnosis made by GPs, junior doctors or epileptologists, as most studies did not explicitly state who made the initial diagnosis. It was apparent that few studies involved epileptologists to determine the final diagnosis which may reflect suboptimal management of epilepsy patients.
Caution is suggested when prescribing AEDs, because when a presenting patient is taking AEDs, doctors' certainty about the diagnosis may be impacted and history taking may be influenced, in which suggestive terms, such as ''warnings'', ''loss of consciousness'', ''tongue biting'' will be used [62] . Conversely, delay in starting treatment does not affect long-term prognosis of first tonic-clonic seizure [63] , early epilepsy or single seizures [64, 65] . Nonetheless, we do not advocate delay if the diagnosis is clear as immediate AEDs treatment increases the time to second seizure and first tonic-clonic seizure, reduces the time to achieve 2-year remission of seizures [64] , and leads to a significant reduction of the risk of relapse [66] .
There are several limitations to this review. The considerable heterogeneity across studies makes a quantitative meta-analysis impossible. Second, the included studies were all conducted in developed countries, but developing countries have a higher median incidence rate of epilepsy (68.7/100,000) than developed countries (43.4/100,000) [1] and likely fewer resources for gold standard diagnosis. Finally, paroxysmal events in children with developmental delay, autism or learning difficulties are often misinterpreted as epilepsy [12] , and they were the predominant differential diagnoses in one study [30] in this review. However, we are unable to provide a comprehensive overview of these groups as we excluded study populations limited by particular characteristics such as those with a disability.
In conclusion, misdiagnosis of epilepsy is common, even though there is considerable heterogeneity across studies. Potential imitators should be considered and clinicians should be cautious introducing AEDs without a definite diagnosis given the risk of side effects, and the possible impact on legal driving status and employment. No funding body had a role in the conduct or reporting of this review. 
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